Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapy-Reference-Cited by-同舟云学术

Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapy

Published:2012-06 Issue:6 Volume:106 Page:829-837
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Dalal Anand A.,Shah Manan,D’Souza Anna O.,Crater Glenn D.

Funder

GlaxoSmithKline (GSK)

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management and prevention of COPD. Updated 2010. Available from: URL: www.goldcopd.com/Guidelineitem.asp?l1=2&;l2=1&intId=989.

2. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease;Donaldson;Thorax,2002

3. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease;Seemungal;Am J Respir Crit Care Med,2000

4. Impact on patients’ health status following early identification of a COPD exacerbation;Bourbeau;Eur Respir J,2007

5. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study;Miravitlles;Thorax,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review;International Journal of Chronic Obstructive Pulmonary Disease;2023-11

2. Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study;International Journal of Chronic Obstructive Pulmonary Disease;2023-10

3. Exacerbations and Real-World Outcomes after Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with Copd: Results from the Eros Study;2023

4. Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study;Journal of Managed Care & Specialty Pharmacy;2022-12

5. A multistate model to evaluate COPD progression integrating drugs consumption data and hospital databases;Epidemiology, Biostatistics, and Public Health;2022-05-10